These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4835640)

  • 1. [Lymphocyte transformation in multiple sclerosis. Demonstration of cell sensitivity to basic myelin protein (author's transl)].
    Frick E; Stickl H; Zinn KH
    Klin Wochenschr; 1974 Mar; 52(5):238-45. PubMed ID: 4835640
    [No Abstract]   [Full Text] [Related]  

  • 2. Multiple sclerosis-lymphocyte transformation with multiple sclerosis and normal brain myelin basic protein and subcellular fractions.
    Hughes RA; Gray IA; Gregson NA; Metcalfe RA
    Acta Neurol Scand; 1982 Mar; 65(3):161-73. PubMed ID: 6177188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune response to myelin basic protein in multiple sclerosis.
    Hughes RA; Gray I; Clifford-Jones R; Stern M
    Proc R Soc Med; 1977 Dec; 70(12):874-6. PubMed ID: 601066
    [No Abstract]   [Full Text] [Related]  

  • 4. Cell-mediated immunity to myelin basic protein in acute disseminated encephalomyelitis.
    Lisak RP; Behan PO; Zweiman B; Shetty T
    Neurology; 1974 Jun; 24(6):560-4. PubMed ID: 4133960
    [No Abstract]   [Full Text] [Related]  

  • 5. Lymphocyte transformation in the presence of myelin basic protein in multiple sclerosis and control subjects.
    Hughes RA; Gray IA; Clifford-Jones R; Stern MA
    Acta Neurol Scand; 1979 Aug; 60(2):65-76. PubMed ID: 91302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte transformation in multiple sclerosis. Inhibition of unstimulated thymidine uptake by a serum factor.
    Knowles M; Hughes D; Caspary EA; Field EJ
    Lancet; 1968 Dec; 2(7580):1207-9. PubMed ID: 4177202
    [No Abstract]   [Full Text] [Related]  

  • 7. Cellular-immune response to myelin protein: absence in multiple sclerosis and presence in cerebrovascular accidents.
    Youngchaiyud U; Coates AS; Whittingham S; Mackay IR
    Aust N Z J Med; 1974 Dec; 4(6):535-8. PubMed ID: 4533943
    [No Abstract]   [Full Text] [Related]  

  • 8. [Lymphocyte transformation by phytohemagglutinin P in multiple sclerosis patients].
    Hierholzer E; Kuwert E
    Verh Dtsch Ges Inn Med; 1973; 79():602-6. PubMed ID: 4790306
    [No Abstract]   [Full Text] [Related]  

  • 9. [Plant agglutinin- and PPD tuberculin-stimulated lymphocyte transformation in vitro in patients with disseminated sclerosis].
    Cendrowski W; Moskalewska K; Plonka T; Niedzielska K
    Neurol Neurochir Pol; 1971; 5(4):485-8. PubMed ID: 4330664
    [No Abstract]   [Full Text] [Related]  

  • 10. Lymphocyte transformation induced in vitro by PHA and PPD in multiple sclerosis.
    Cendrowski W; Niedzielska K
    J Neurol Neurosurg Psychiatry; 1970 Feb; 33(1):92-4. PubMed ID: 5418184
    [No Abstract]   [Full Text] [Related]  

  • 11. Polymorphonuclear leukocyte lysosome activities and lymphocyte transformation in multiple sclerosis and some other central nervous system chronic diseases.
    Tchórzewski H; Czernicki J; Maciejek Z
    Eur Neurol; 1976; 14(5):386-96. PubMed ID: 949988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocyte stimulation with phytohaemagglutinin in multiple sclerosis.
    Saunders M; Knowles M; Field EJ
    Lancet; 1969 Mar; 1(7596):674-5. PubMed ID: 4179907
    [No Abstract]   [Full Text] [Related]  

  • 13. Lymphocyte transformation by phytohaemagglutinin (PHA) and purified protein derivative (PPD) in primary biliary cirrhosis. Evidence of serum inhibitory factors.
    MacSween RN; Thomas MA
    Clin Exp Immunol; 1973 Dec; 15(4):523-33. PubMed ID: 4544318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sensitization against the antigens of the brain after experimental vaccinia infection. I. Evidence for cell-mediated immune response to brain-antigens (author's transl)].
    Huber HC; Zinn KH; Hochstein-Mintzel V; Simon J; Stickl H
    Zentralbl Bakteriol Orig A; 1975 Jun; 232(1):1-7. PubMed ID: 51549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of antilymphocytic globulin therapy in chronic progressive multiple sclerosis.
    MacFadyen DJ; Reeve CE; Bratty PJ; Thomas JW
    Neurology; 1973 Jun; 23(6):592-8. PubMed ID: 4541183
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effect of I-125 labeled encephalitogenic protein on the surface of blood lymphocytes].
    Diessner H; Neumann V; Schmidt RM
    Schweiz Arch Neurol Neurochir Psychiatr; 1974; 114(1):57-66. PubMed ID: 4133176
    [No Abstract]   [Full Text] [Related]  

  • 17. CD4 T cell activation and disease activity at onset of multiple sclerosis.
    Jensen J; Langkilde AR; Fenst C; Nicolaisen MS; Roed HG; Christiansen M; Sellebjerg F
    J Neuroimmunol; 2004 Apr; 149(1-2):202-9. PubMed ID: 15020081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte trnsformation induced by encephalitogenic factor in multiple sclerosis and other neurological diseases.
    Hughes D; Caspary EA; Field EJ
    Lancet; 1968 Dec; 2(7580):1205-7. PubMed ID: 4177201
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cellular immunity in neurological diseases. Results with myelinbasic protein (author's transl)].
    Meyer-Rienecker H; Jenssen HL; Köhler H; Lehmitz R; Schmieter K
    Nervenarzt; 1979 Jan; 50(1):10-5. PubMed ID: 85265
    [No Abstract]   [Full Text] [Related]  

  • 20. Early activation of CD4+ and CD8+ T lymphocytes by myelin basic protein in subjects with MS.
    Arneth B
    J Transl Med; 2015 Nov; 13():341. PubMed ID: 26526848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.